Organ and cell-specific biomarkers of Long-COVID identified with targeted proteomics and machine learning

[1]  Claudio M. Martin,et al.  COVID‐19 plasma proteome reveals novel temporal and cell‐specific signatures for disease severity and high‐precision disease management , 2022, Journal of cellular and molecular medicine.

[2]  Claudio M. Martin,et al.  Novel plasma protein biomarkers from critically ill sepsis patients , 2022, Clinical Proteomics.

[3]  Shannon Seney,et al.  Elevated vascular transformation blood biomarkers in Long-COVID indicate angiogenesis as a key pathophysiological mechanism , 2022, Molecular Medicine.

[4]  S. Herzig,et al.  Vps37a regulates hepatic glucose production by controlling glucagon receptor localization to endosomes. , 2022, Cell metabolism.

[5]  Z. Al-Aly,et al.  Long-term neurologic outcomes of COVID-19 , 2022, Nature Medicine.

[6]  N. Dutt,et al.  A distinct symptom pattern emerges for COVID-19 long-haul: a nationwide study , 2022, Scientific Reports.

[7]  A. Greinacher,et al.  GPVI expression is linked to platelet size, age, and reactivity , 2022, Blood advances.

[8]  B. Engelhardt,et al.  COVID-19 and the Vasculature: Current Aspects and Long-Term Consequences , 2022, Frontiers in Cell and Developmental Biology.

[9]  P. Gautret,et al.  Clinical patterns of somatic symptoms in patients suffering from post-acute long COVID: a systematic review , 2022, European Journal of Clinical Microbiology & Infectious Diseases.

[10]  Benjamin Bowe,et al.  Long-term cardiovascular outcomes of COVID-19 , 2022, Nature Medicine.

[11]  Kento Sato,et al.  Role of CC Chemokine Ligand 17 in Mouse Models of Chronic Obstructive Pulmonary Disease. , 2022, American journal of respiratory cell and molecular biology.

[12]  W. Ouwehand,et al.  Platelet surface receptor glycoprotein VI-dimer is overexpressed in stroke: The Glycoprotein VI in Stroke (GYPSIE) study results , 2022, PloS one.

[13]  S. Ng,et al.  Gut microbiota dynamics in a prospective cohort of patients with post-acute COVID-19 syndrome , 2022, Gut.

[14]  Y. Gwack,et al.  Biallelic mutations in calcium release activated channel regulator 2A (CRACR2A) cause a primary immunodeficiency disorder , 2021, eLife.

[15]  W. Travis,et al.  Lung epithelial and endothelial damage, loss of tissue repair, inhibition of fibrinolysis, and cellular senescence in fatal COVID-19 , 2021, Science Translational Medicine.

[16]  G. Poudel,et al.  Short-term and Long-term Rates of Postacute Sequelae of SARS-CoV-2 Infection , 2021, JAMA network open.

[17]  S. Hill,et al.  Role of the Renin–Angiotensin–Aldosterone and Kinin–Kallikrein Systems in the Cardiovascular Complications of COVID-19 and Long COVID , 2021, International journal of molecular sciences.

[18]  P. Edison,et al.  Long covid—mechanisms, risk factors, and management , 2021, BMJ.

[19]  Ruo-Pan Huang,et al.  Comprehensive Profiling of Inflammatory Factors Revealed That Growth Differentiation Factor-15 Is an Indicator of Disease Severity in COVID-19 Patients , 2021, Frontiers in Immunology.

[20]  Ryan J. Low,et al.  Characterizing long COVID in an international cohort: 7 months of symptoms and their impact , 2021, EClinicalMedicine.

[21]  T. Triche,et al.  Persistence of SARS CoV-2 S1 Protein in CD16+ Monocytes in Post-Acute Sequelae of COVID-19 (PASC) up to 15 Months Post-Infection , 2021, bioRxiv.

[22]  E. Diamandis,et al.  Novel severe traumatic brain injury blood outcome biomarkers identified with proximity extension assay , 2021, Clinical chemistry and laboratory medicine.

[23]  J. Berzofsky,et al.  SARS-CoV-2 Spike Protein Suppresses ACE2 and Type I Interferon Expression in Primary Cells From Macaque Lung Bronchoalveolar Lavage , 2021, Frontiers in Immunology.

[24]  W. Ongkeko,et al.  COVID-19 Severity Potentially Modulated by Cardiovascular-Disease-Associated Immune Dysregulation , 2021, Viruses.

[25]  D. Kell,et al.  Persistent clotting protein pathology in Long COVID/Post-Acute Sequelae of COVID-19 (PASC) is accompanied by increased levels of antiplasmin , 2021, Cardiovascular Diabetology.

[26]  F. Roufosse,et al.  What does elevated TARC/CCL17 expression tell us about eosinophilic disorders? , 2021, Seminars in immunopathology.

[27]  L. Jie,et al.  GTPBP2 positively regulates the invasion, migration and proliferation of non-small cell lung cancer , 2021, Journal of Cancer.

[28]  A. Tsakris,et al.  Post-COVID Syndrome: An Insight on Its Pathogenesis , 2021, Vaccines.

[29]  R. Jayadevan,et al.  Long COVID: An overview , 2021, Diabetes & Metabolic Syndrome: Clinical Research & Reviews.

[30]  Khalid J. Alzahrani,et al.  Long-COVID and Post-COVID Health Complications: An Up-to-Date Review on Clinical Conditions and Their Possible Molecular Mechanisms , 2021, Viruses.

[31]  A. Malhotra,et al.  SARS-CoV-2 Spike Protein Impairs Endothelial Function via Downregulation of ACE 2 , 2021, Circulation research.

[32]  C. Missouris,et al.  Covid-19, hypokalaemia and the renin-angiotensin-aldosterone system , 2021, Annals of Medicine and Surgery.

[33]  D. Brodie,et al.  Post-acute COVID-19 syndrome , 2021, Nature Medicine.

[34]  C. Colak,et al.  Artificial Intelligence-Based Prediction of Covid-19 Severity on the Results of Protein Profiling , 2021, Comput. Methods Programs Biomed..

[35]  Md. Shahriare Satu,et al.  Diseasome and comorbidities complexities of SARS-CoV-2 infection with common malignant diseases , 2021, Briefings Bioinform..

[36]  R. Franco,et al.  Experimental data using candesartan and captopril indicate no double-edged sword effect in COVID-19 , 2021, Clinical science.

[37]  K. Skorecki,et al.  Kinins and chymase: the forgotten components of the renin-angiotensin system and their implications in COVID-19 disease , 2021, American journal of physiology. Lung cellular and molecular physiology.

[38]  Guohui Fan,et al.  RETRACTED: 6-month consequences of COVID-19 in patients discharged from hospital: a cohort study , 2021, The Lancet.

[39]  A. Oliviero,et al.  Neuropsychological and neurophysiological correlates of fatigue in post-acute patients with neurological manifestations of COVID-19: Insights into a challenging symptom , 2020, Journal of the Neurological Sciences.

[40]  Peter B. McGarvey,et al.  UniProt: the universal protein knowledgebase in 2021 , 2020, Nucleic Acids Res..

[41]  Christopher D. Manning,et al.  Biomedical and Clinical English Model Packages in the Stanza Python NLP Library , 2020, ArXiv.

[42]  Ryan J. Low,et al.  Characterizing long COVID in an international cohort: 7 months of symptoms and their impact , 2020, EClinicalMedicine.

[43]  J. Guevara-Coto,et al.  Immune-Based Prediction of COVID-19 Severity and Chronicity Decoded Using Machine Learning , 2020, bioRxiv.

[44]  R. Sutton,et al.  Autonomic dysfunction in 'long COVID': rationale, physiology and management strategies. , 2020, Clinical medicine.

[45]  Guiqiang Wang,et al.  Discharge may not be the end of treatment: Pay attention to pulmonary fibrosis caused by severe COVID‐19 , 2020, Journal of medical virology.

[46]  Penghua Wang,et al.  Mechanisms of SARS-CoV-2 Transmission and Pathogenesis , 2020, Trends in Immunology.

[47]  D. Wishart,et al.  Metabolomics Profiling of Critically Ill Coronavirus Disease 2019 Patients: Identification of Diagnostic and Prognostic Biomarkers , 2020, Critical care explorations.

[48]  Xuequan Huang,et al.  Pathological changes in the lungs and lymphatic organs of 12 COVID-19 autopsy cases , 2020, National science review.

[49]  K. Bosma,et al.  Transcriptional profiling of leukocytes in critically ill COVID19 patients: implications for interferon response and coagulation , 2020, Intensive Care Medicine Experimental.

[50]  K. Bosma,et al.  Endothelial Injury and Glycocalyx Degradation in Critically Ill Coronavirus Disease 2019 Patients: Implications for Microvascular Platelet Aggregation , 2020, Critical care explorations.

[51]  E. Diamandis,et al.  Novel Outcome Biomarkers Identified With Targeted Proteomic Analyses of Plasma From Critically Ill Coronavirus Disease 2019 Patients , 2020, Critical care explorations.

[52]  J. Casanova,et al.  Human inborn errors of immunity: An expanding universe , 2020, Science Immunology.

[53]  Angelo Carfì,et al.  Persistent Symptoms in Patients After Acute COVID-19. , 2020, JAMA.

[54]  K. Khunti,et al.  New-Onset Diabetes in Covid-19 , 2020, The New England journal of medicine.

[55]  D. O'Gorman,et al.  Inflammation Profiling of Critically Ill Coronavirus Disease 2019 Patients , 2020, Critical care explorations.

[56]  Axel Haverich,et al.  Pulmonary Vascular Endothelialitis, Thrombosis, and Angiogenesis in Covid-19. , 2020, The New England journal of medicine.

[57]  F. Priestap,et al.  External validation of a prognostic model for intensive care unit mortality: a retrospective study using the Ontario Critical Care Information System , 2020, Canadian Journal of Anesthesia/Journal canadien d'anesthésie.

[58]  Laura C Myers,et al.  Characteristics of Hospitalized Adults With COVID-19 in an Integrated Health Care System in California. , 2020, JAMA.

[59]  Koichi Yuki,et al.  COVID-19 pathophysiology: A review , 2020, Clinical Immunology.

[60]  T. West,et al.  Covid-19 in Critically Ill Patients in the Seattle Region — Case Series , 2020, The New England journal of medicine.

[61]  Christopher D. Manning,et al.  Stanza: A Python Natural Language Processing Toolkit for Many Human Languages , 2020, ACL.

[62]  Xin Zhou,et al.  Risk Factors Associated With Acute Respiratory Distress Syndrome and Death in Patients With Coronavirus Disease 2019 Pneumonia in Wuhan, China , 2020, The Journal of Emergency Medicine.

[63]  J. Xiang,et al.  Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study , 2020, The Lancet.

[64]  Q. Zhan,et al.  PEAR1 suppresses the proliferation of pulmonary microvascular endothelial cells via PI3K/AKT pathway in ALI model. , 2020, Microvascular research.

[65]  Ulrike von Luxburg,et al.  When do random forests fail? , 2018, NeurIPS.

[66]  J. Park,et al.  Functional intronic variant of SLC5A10 affects DRG2 expression and survival outcomes of early‐stage non‐small‐cell lung cancer , 2018, Cancer science.

[67]  J. Bonifacino,et al.  Neuronal functions of adaptor complexes involved in protein sorting , 2018, Current Opinion in Neurobiology.

[68]  C. Wohlford-Lenane,et al.  Attenuation of pulmonary ACE2 activity impairs inactivation of des-Arg9 bradykinin/BKB1R axis and facilitates LPS-induced neutrophil infiltration. , 2018, American journal of physiology. Lung cellular and molecular physiology.

[69]  Qingxiao Fang,et al.  The Gas6 gene rs8191974 and Ap3s2 gene rs2028299 are associated with type 2 diabetes in the northern Chinese Han population. , 2017, Acta biochimica Polonica.

[70]  R. Nusse,et al.  Wnt/β-Catenin Signaling, Disease, and Emerging Therapeutic Modalities , 2017, Cell.

[71]  L. Tsai,et al.  Subarachnoid Hemorrhage Promotes Proliferation, Differentiation, and Migration of Neural Stem Cells via BDNF Upregulation , 2016, PloS one.

[72]  Y. Gwack,et al.  A large Rab GTPase encoded by CRACR2A is a component of subsynaptic vesicles that transmit T cell activation signals , 2016, Science Signaling.

[73]  R. Bellomo,et al.  The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3). , 2016, JAMA.

[74]  N. Flamand,et al.  Correlation between CCL26 production by human bronchial epithelial cells and airway eosinophils: Involvement in patients with severe eosinophilic asthma. , 2015, The Journal of allergy and clinical immunology.

[75]  M. Boehnke,et al.  Recent advances in understanding the genetic architecture of type 2 diabetes. , 2015, Human molecular genetics.

[76]  É. Thorin,et al.  Angiopoietin-like-2: a multifaceted protein with physiological and pathophysiological properties , 2014, Expert Reviews in Molecular Medicine.

[77]  A. Poole,et al.  Syntaxin 8 Regulates Platelet Dense Granule Secretion, Aggregation, and Thrombus Stability* , 2014, The Journal of Biological Chemistry.

[78]  J. Stenvang,et al.  Homogenous 96-Plex PEA Immunoassay Exhibiting High Sensitivity, Specificity, and Excellent Scalability , 2014, PloS one.

[79]  D. Riese,et al.  Epiregulin: roles in normal physiology and cancer. , 2014, Seminars in cell & developmental biology.

[80]  A. Elfiky,et al.  The role of Src in colon cancer and its therapeutic implications. , 2014, Clinical colorectal cancer.

[81]  A. Russell,et al.  Integrated phenotypic and activity-based profiling links Ces3 to obesity and diabetes , 2013, Nature chemical biology.

[82]  E. García-Zepeda,et al.  The multiple faces of CCL13 in immunity and inflammation , 2013, Inflammopharmacology.

[83]  D. Fraser,et al.  Translational Research in Pediatrics II: Blood Collection, Processing, Shipping, and Storage , 2013, Pediatrics.

[84]  Ju-Young Kim,et al.  Secreted frizzled-related protein 3 regulates activity-dependent adult hippocampal neurogenesis. , 2013, Cell stem cell.

[85]  R. Djukanović,et al.  Phenotypic characterization of lung macrophages in asthmatic patients: overexpression of CCL17. , 2012, The Journal of allergy and clinical immunology.

[86]  N. Copeland,et al.  Bcl11a is required for neuronal morphogenesis and sensory circuit formation in dorsal spinal cord development , 2012, Development.

[87]  M. Urioste,et al.  MAX Mutations Cause Hereditary and Sporadic Pheochromocytoma and Paraganglioma , 2012, Clinical Cancer Research.

[88]  M. Rieder,et al.  Translational Research in Pediatrics: Tissue Sampling and Biobanking , 2012, Pediatrics.

[89]  Hey-Kyoung Lee,et al.  The Upside of APP at Synapses , 2012, CNS neuroscience & therapeutics.

[90]  Tien Yin Wong,et al.  Genome-wide association study in individuals of South Asian ancestry identifies six new type 2 diabetes susceptibility loci , 2011, Nature Genetics.

[91]  J. Benítez,et al.  Exome sequencing identifies MAX mutations as a cause of hereditary pheochromocytoma , 2011, Nature Genetics.

[92]  P. Wong,et al.  Amyloid precursor protein processing and Alzheimer's disease. , 2011, Annual review of neuroscience.

[93]  Martin Lundberg,et al.  Homogeneous antibody-based proximity extension assays provide sensitive and specific detection of low-abundant proteins in human blood , 2011, Nucleic acids research.

[94]  Gaël Varoquaux,et al.  Scikit-learn: Machine Learning in Python , 2011, J. Mach. Learn. Res..

[95]  Witold R. Rudnicki,et al.  Feature Selection with the Boruta Package , 2010 .

[96]  V. Dolinsky,et al.  Loss of TGH/Ces3 in mice decreases blood lipids, improves glucose tolerance, and increases energy expenditure. , 2010, Cell metabolism.

[97]  T. Shiomi,et al.  Macrophage derived chemokine (CCL22), thymus and activation-regulated chemokine (CCL17), and CCR4 in idiopathic pulmonary fibrosis , 2009, Respiratory research.

[98]  A. Fourie.  Modulation of inflammatory disease by inhibitors of leukotriene A4 hydrolase. , 2009, Current opinion in investigational drugs.

[99]  A. Ben-Baruch,et al.  The inflammatory chemokines CCL2 and CCL5 in breast cancer. , 2008, Cancer letters.

[100]  Geoffrey E. Hinton,et al.  Visualizing Data using t-SNE , 2008 .

[101]  E. Ono,et al.  Circulating thymus- and activation-regulated chemokine/CCL17 is a useful biomarker for discriminating acute eosinophilic pneumonia from other causes of acute lung injury. , 2007, Chest.

[102]  D. Rujescu,et al.  Plexin B3 is genetically associated with verbal performance and white matter volume in human brain , 2007, Molecular Psychiatry.

[103]  K. Alitalo,et al.  Signaling and Functions of Angiopoietin-1 in Vascular Protection , 2006, Circulation research.

[104]  G. Rosenberger,et al.  Plexin B3 promotes neurite outgrowth, interacts homophilically, and interacts with Rin , 2005, BMC Neuroscience.

[105]  Hilde van der Togt,et al.  Publisher's Note , 2003, J. Netw. Comput. Appl..

[106]  B. Nieswandt,et al.  Platelet glycoprotein V binds to collagen and participates in platelet adhesion and aggregation. , 2001, Blood.

[107]  T. Dale,et al.  Signal transduction by the Wnt family of ligands. , 1998, The Biochemical journal.

[108]  Andrew P. Bradley,et al.  The use of the area under the ROC curve in the evaluation of machine learning algorithms , 1997, Pattern Recognit..

[109]  R. Basu,et al.  Cloning and characterization of the human neutrophil-activating peptide (ENA-78) gene. , 1994, The Journal of biological chemistry.

[110]  A. Mantovani,et al.  Chemokines , 1994, The Lancet.

[111]  Michel Jambu,et al.  Chapter 10 – Classification of Individuals–Variables Data Sets , 1991 .